Related references
Note: Only part of the references are listed.Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer
Niels H. H. Heegaard et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer
Kyong-Ah Yoon et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2012)
EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers
Michela Garofalo et al.
NATURE MEDICINE (2012)
MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation
Giulia Romano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The Blocking of c-Met Signaling Induces Apoptosis through the Increase of p53 Protein in Lung Cancer
Hae-Yun Jung et al.
CANCER RESEARCH AND TREATMENT (2012)
Tolfenamic acid decreases c-Met expression through Sp proteins degradation and inhibits lung cancer cells growth and tumor formation in orthotopic mice
Jimmie Colon et al.
INVESTIGATIONAL NEW DRUGS (2011)
Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells
Xiaohong Zhao et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
Met Activation in Non-Small Cell Lung Cancer Is Associated with de Novo Resistance to EGFR Inhibitors and the Development of Brain Metastasis
Elisa Benedettini et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2
Yihui Ma et al.
CANCER LETTERS (2010)
Does hepatocyte growth factor/c-Met signal play synergetic role in lung cancer?
Xiangdong Wang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Cooperative and individualistic functions of the microRNAs in the miR-23a∼27a∼24-2 cluster and its implication in human diseases
Ravindresh Chhabra et al.
MOLECULAR CANCER (2010)
Sprouty-2 controls c-Met expression and metastatic potential of colon cancer cells: sprouty/c-Met upregulation in human colonic adenocarcinomas
C. Holgren et al.
ONCOGENE (2010)
A network connecting Runx2, SATB2, and the miR-23a∼27a∼24-2 cluster regulates the osteoblast differentiation program
Mohammad Q. Hassan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation
Michela Garofalo et al.
CANCER CELL (2009)
MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin
Tao Liu et al.
CANCER LETTERS (2009)
Coordinate Regulation of FOXO1 by miR-27a, miR-96, and miR-182 in Breast Cancer Cells
Irene K. Guttilla et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Causes and consequences of microRNA dysregulation in cancer
Carlo M. Croce
NATURE REVIEWS GENETICS (2009)
Upregulation of miR-23a∼27a∼24-2 Cluster Induces Caspase-Dependent and -Independent Apoptosis in Human Embryonic Kidney Cells
Ravindresh Chhabra et al.
PLOS ONE (2009)
The Met tyrosine kinase receptor in development and cancer
Alessandra Gentile et al.
CANCER AND METASTASIS REVIEWS (2008)
Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer
Ken-ichi Kozaki et al.
CANCER RESEARCH (2008)
Upregulation of miR-23a∼27a∼24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells
Shenglin Huang et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
The shadow of death on the MET tyrosine kinase receptor
D. Tulasne et al.
CELL DEATH AND DIFFERENTIATION (2008)
The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells
Susanne U. Mertens-Talcott et al.
CANCER RESEARCH (2007)
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling
Jeffrey A. Engelman et al.
SCIENCE (2007)
Spatial regulation of EGFR signaling by Sprouty2
Hong Joo Kim et al.
CURRENT BIOLOGY (2007)
A microRNA expression signature of human solid tumors defines cancer gene targets
S Volinia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
miR-15 and miR-16 induce apoptosis by targeting BCL2
A Cimmino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The SPRY domain-containing SOCS box protein 1 (SSB-1) interacts with MET and enhances the hepatocyte growth factor-induced Erk-Elk-1-serum response element pathway
DK Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Functional expression and mutations of c-met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer
PC Ma et al.
CANCER RESEARCH (2005)
The biology of epidermal growth factor receptor in lung cancer
GV Scagliotti et al.
CLINICAL CANCER RESEARCH (2004)
Tyrosine phosphorylation of Sprouty2 enhances its interaction with c-Cbl and is crucial for its function
CW Fong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Sprouty fine-tunes EGF signaling through interlinked positive and negative feedback loops
C Rubin et al.
CURRENT BIOLOGY (2003)
Sprouty2 attenuates epidermal growth factor receptor ubiquitylation and endocytosis, and consequently enhances Ras/ERK signalling
ESM Wong et al.
EMBO JOURNAL (2002)
Large-scale analysis of the human and mouse transcriptomes
AI Su et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Share Paper
